Physician profile
John Amerson
NPI 1205414554
$590.87
in general payments reported to CMS, 2019-2025
9 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $91.87 · 2023: $134 · 2024: $16.13 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $127.00 | 2025 | |
| Mallinckrodt Hospital Products INC. | $126.35 | 2025 | Terlivaz |
| Nestle Healthcare Nutrition INC. | $113.26 | 2023 | |
| Medtronic, INC. | $57.99 | 2022 | |
| Abbvie INC. | $54.40 | 2022-2023 | Rinvoq |
| Vantive US Healthcare LLC | $45.30 | 2025 | Renal - Acute |
| Outset Medical INC | $29.02 | 2025 | |
| Ardelyx, INC. | $21.42 | 2025 | Ibsrela |
| Janssen Pharmaceuticals, INC | $16.13 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Amerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.